• Sleep Breath · May 2018

    Polysomnographic determinants of requirement for advanced positive pressure therapeutic options for obstructive sleep apnea.

    • Anupama Gupta and Garima Shukla.
    • Comprehensive Sleep Disorders Facility, Department of Neurology, Neurosciences Center, All India Institute of Medical Sciences, Room #2, 6th floor, New Delhi, 110049, India.
    • Sleep Breath. 2018 May 1; 22 (2): 401-409.

    BackgroundA small percentage of adult patients with severe obstructive sleep apnea (OSA) has been recognized to be extraordinarily difficult to treat with conventional continuous or Bi-level positive airway pressure (together referred to as PAP) therapy.Aim And ObjectivesThe aim of this study was to determine polysomnographic (PSG) characteristics, which may help predict the requirement for advanced therapeutic options for OSA.MethodsConsecutive patients who underwent PAP titration at our sleep laboratory over a 2-year period were included. Patients with technically inadequate studies, those with incomplete titration due to intolerance, mask-related problems, or lack of sleep and those with significant co-morbidity and with other primary sleep disorders, were excluded. The PSGs (diagnostic + titration parts) were categorized into three types: type A (respiratory events evenly distributed over all sleep stages), type B (REM dominant respiratory events), and type C (non-REM dominant respiratory events, mainly during cyclic alternating pattern [CAP] sleep). Group A was further subdivided into A1 (those whose hypnogram normalized after adequate titration) and A2 (those whose hypnogram converted to a type C pattern on titration). These were categorized again into treatment group I (adequately PAP titrated) and group II (poor response to conventional PAP) for studying factors determining poor response to PAP.ResultsAmong 249 patients evaluated in the sleep laboratory over the study period, 123 (103 males, mean age 49.9 ± 10.8 years, mean BMI 29.3 ± 4) fulfilled inclusion criteria. These could be grouped as type A (n = 85), B (n = 33), and C (n = 5). On titration, 57 patients of type A and 21 of type B could be successfully titrated, while 24 in type A and 11 in type B, converted into type C. Therefore, in group II (n = 43), 38 patients fell in type C, overtly and after titration. Twelve of these had been successfully treated using adaptive servo ventilation (ASV) while another 28 could be treated using the Bi-level PAP-ST mode. The only PSG feature predicting poor response to conventional PAP was the presence of post-arousal central apnea (p = 0.001). The main difference between the A1 + B groups and A2 + C groups was the significantly higher non-REM apnea hypopnea index in the latter. Among these, on 1-year follow-up, eight patients were using Bi-level PAP-ST mode, while four patients were using ASV and were asymptomatic.ConclusionNon-REM sleep instability and the presence of post-arousal central apneas may be important determinants of poor response to conventional PAP and requirement for advanced therapeutic options among patients with severe OSA.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.